Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ MAFK Monoclonal Antibody (1328CT786.105.125)
Mouse Monoclonal Antibody
Supplier: Invitrogen™ MA524732
Description
MAFK Monoclonal Antibody for Western Blot, Flow
Since they lack a putative transactivation domain, the small Mafs behave as transcriptional repressors when they dimerize among themselves. However, they seem to serve as transcriptional activators by dimerizing with other (usually larger) basic-zipper proteins and recruiting them to specific DNA-binding sites. Small Maf proteins heterodimerize with Fos and may act as competitive repressors of the NF-E2 transcription factor.
Specifications
MAFK | |
Monoclonal | |
0.38 mg/mL | |
PBS with 0.09% sodium azide; pH 7.4 | |
O60675 | |
MAFK | |
KLH conjugated synthetic peptide of human MAFK. | |
400 μL | |
Primary | |
Human | |
Antibody | |
IgG1 κ |
Flow Cytometry, Western Blot | |
1328CT786.105.125 | |
Unconjugated | |
MAFK | |
AW061068; basic-leucine zipper transcription factor MafK; erythroid transcription factor NF-E2 p18 subunit; FLJ32205; MAF bZIP transcription factor K; Mafk; MGC71717; NF-E2; Nfe2u; nuclear factor erythroid-2, ubiquitous (p18); nuclear factor, erythroid derived 2, ubiquitous; P18; p18 NF-E2; transcription factor MafK; v-maf avian musculoaponeurotic fibrosarcoma oncogene family, protein K; v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog K; v-maf musculoaponeurotic fibrosarcoma oncogene family, protein K; v-maf musculoaponeurotic fibrosarcoma oncogene family, protein K (avian); v-maf musculoaponeurotic fibrosarcoma oncogene homolog K | |
Mouse | |
Protein G | |
RUO | |
7975 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction